Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2026-05-23 @ 8:22 AM
Study NCT ID:
NCT00642902
Status:
TERMINATED
Last Update Posted:
2016-05-24
First Post:
2008-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
Sponsor:
EMD Serono
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
28063
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None